Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Artery Stenting in Resistant Hypertension (ANDORRA)
NCT02539810Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in resistant hypertension (RH) and atherosclerotic renal artery stenosis (ARAS) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Mean change in diurnal systolic blood pressure assessed by ambulatory BP monitoring (ABPM) at 6 months. Started Sep 2015; status: terminated.
02
Conditions
resistant hypertension (RH)atherosclerotic renal artery stenosis (ARAS)
Beyond the preview
Go deeper on NCT02539810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02539810.